Ma Private Wealth Bristol Myers Squibb CO Transaction History

Ma Private Wealth

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $547 - $648	8 Added 0.22%	3,674 $264,000
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $1 - $614	8 Added 0.22%	3,666 $268,000
Q2 2022 Jul 14, 2022	SELL	$72.62 - $79.98 $20,769 - $22,874	-286 Reduced 7.25%	3,658 $273,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $1,475 - $1,769	24 Added 0.61%	3,944 $288,000
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $6,167 - $7,189	115 Added 3.02%	3,920 $244,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $1,183 - $1,386	20 Added 0.53%	3,805 $225,000
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $557 - $606	-9 Reduced 0.24%	3,785 $253,000
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $225,135 - $253,211	3,794 New	3,794 $240,000
Q4 2020 Jan 11, 2021	SELL	$57.74 - $65.43 $228,073 - $258,448	-3,950 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $1,206 - $1,336	21 Added 0.53%	3,950 $238,000
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $1,041 - $1,217	19 Added 0.49%	3,929 $231,000
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $1,113 - $1,618	24 Added 0.62%	3,910 $218,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $191,230 - $249,442	3,886 New	3,886 $249,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ma Private Wealth, based on Form 13F filings with the SEC.

Stay updated on Ma Private Wealth with notifications on news.